A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dubé syndrome.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
09 2020
Historique:
received: 03 12 2019
accepted: 27 04 2020
pubmed: 3 7 2020
medline: 21 10 2020
entrez: 3 7 2020
Statut: ppublish

Résumé

The mechanistic target of rapamycin complex 1 (mTORC1) is a key metabolic hub that controls the cellular response to environmental cues by exerting its kinase activity on multiple substrates

Identifiants

pubmed: 32612235
doi: 10.1038/s41586-020-2444-0
pii: 10.1038/s41586-020-2444-0
pmc: PMC7610377
mid: EMS114552
doi:

Substances chimiques

Basic Helix-Loop-Helix Leucine Zipper Transcription Factors 0
Bhd protein, mouse 0
Proto-Oncogene Proteins 0
RHEB protein, human 0
RRAGC protein, human 0
RRAGD protein, human 0
Ras Homolog Enriched in Brain Protein 0
TFEB protein, human 0
TSC2 protein, human 0
Tcfeb protein, mouse 0
Tuberous Sclerosis Complex 2 Protein 0
Tumor Suppressor Proteins 0
Mechanistic Target of Rapamycin Complex 1 EC 2.7.11.1
Monomeric GTP-Binding Proteins EC 3.6.5.2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

597-602

Subventions

Organisme : European Research Council
ID : 694282
Pays : International
Organisme : NINDS NIH HHS
ID : R01 NS078072
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Liu, G. Y. & Sabatini, D. M. mTOR at the nexus of nutrition, growth, ageing and disease. Nat. Rev. Mol. Cell Biol. 21, 183–203 (2020).
pubmed: 31937935
Ben-Sahra, I. & Manning, B. D. mTORC1 signaling and the metabolic control of cell growth. Curr. Opin. Cell Biol. 45, 72–82 (2017).
pubmed: 28411448 pmcid: 5545101
González, A. & Hall, M. N. Nutrient sensing and TOR signaling in yeast and mammals. EMBO J. 36, 397–408 (2017).
pubmed: 28096180 pmcid: 5694944
Sardiello, M. et al. A gene network regulating lysosomal biogenesis and function. Science 325, 473–477 (2009).
pubmed: 19556463
Settembre, C. et al. TFEB links autophagy to lysosomal biogenesis. Science 332, 1429–1433 (2011).
pubmed: 21617040 pmcid: 3638014
Schmidt, L. S. & Linehan, W. M. FLCN: the causative gene for Birt–Hogg–Dubé syndrome. Gene 640, 28–42 (2018).
pubmed: 28970150
Schmidt, L. S. & Linehan, W. M. Molecular genetics and clinical features of Birt–Hogg–Dubé syndrome. Nat. Rev. Urol. 12, 558–569 (2015).
pubmed: 26334087 pmcid: 5119524
Inoki, K., Li, Y., Xu, T. & Guan, K. L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17, 1829–1834 (2003).
pubmed: 12869586 pmcid: 196227
Long, X., Lin, Y., Ortiz-Vega, S., Yonezawa, K. & Avruch, J. Rheb binds and regulates the mTOR kinase. Curr. Biol. 15, 702–713 (2005).
pubmed: 15854902
Tee, A. R., Manning, B. D., Roux, P. P., Cantley, L. C. & Blenis, J. Tuberous sclerosis complex gene products, tuberin and hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 13, 1259–1268 (2003).
pubmed: 12906785
Yang, H. et al. Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40. Nature 552, 368–373 (2017).
pubmed: 29236692 pmcid: 5750076
Sancak, Y. et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496–1501 (2008).
pubmed: 18497260 pmcid: 2475333
Sancak, Y. et al. Ragulator–Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141, 290–303 (2010).
pubmed: 20381137 pmcid: 3024592
Kim, E., Goraksha-Hicks, P., Li, L., Neufeld, T. P. & Guan, K. L. Regulation of TORC1 by Rag GTPases in nutrient response. Nat. Cell Biol. 10, 935–945 (2008).
pubmed: 18604198 pmcid: 2711503
Bar-Peled, L. et al. A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science 340, 1100–1106 (2013).
pubmed: 23723238 pmcid: 3728654
Tsun, Z. Y. et al. The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1. Mol. Cell 52, 495–505 (2013).
pubmed: 24095279
Lawrence, R. E. et al. Structural mechanism of a Rag GTPase activation checkpoint by the lysosomal folliculin complex. Science 366, 971–977 (2019).
pubmed: 31672913 pmcid: 6945816
Shen, K. et al. Cryo-EM structure of the human FLCN–FNIP2–Rag–Ragulator complex. Cell 179, 1319–1329.e8 (2019).
pubmed: 31704029
Settembre, C. et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 31, 1095–1108 (2012).
pubmed: 22343943 pmcid: 3298007
Martina, J. A., Chen, Y., Gucek, M. & Puertollano, R. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 8, 903–914 (2012).
pubmed: 22576015 pmcid: 3427256
Roczniak-Ferguson, A. et al. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci. Signal. 5, ra42 (2012).
pubmed: 22692423 pmcid: 3437338
Napolitano, G. et al. mTOR-dependent phosphorylation controls TFEB nuclear export. Nat. Commun. 9, 3312 (2018).
pubmed: 30120233 pmcid: 6098152
Medina, D. L. et al. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat. Cell Biol. 17, 288–299 (2015).
pubmed: 25720963 pmcid: 4801004
Ballabio, A. & Bonifacino, J. S. Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat. Rev. Mol. Cell Biol. 21, 101–118 (2019).
pubmed: 31768005
Di Malta, C. et al. Transcriptional activation of RagD GTPase controls mTORC1 and promotes cancer growth. Science 356, 1188–1192 (2017).
pubmed: 28619945 pmcid: 5730647
Martina, J. A. & Puertollano, R. Rag GTPases mediate amino acid-dependent recruitment of TFEB and MITF to lysosomes. J. Cell Biol. 200, 475–491 (2013).
pubmed: 23401004 pmcid: 3575543
Schalm, S. S. & Blenis, J. Identification of a conserved motif required for mTOR signaling. Curr. Biol. 12, 632–639 (2002).
pubmed: 11967149
Schalm, S. S., Fingar, D. C., Sabatini, D. M. & Blenis, J. TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function. Curr. Biol. 13, 797–806 (2003).
pubmed: 12747827
Lawrence, R. E. et al. A nutrient-induced affinity switch controls mTORC1 activation by its Rag GTPase–Ragulator lysosomal scaffold. Nat. Cell Biol. 20, 1052–1063 (2018).
pubmed: 30061680 pmcid: 6279252
Baba, M. et al. Kidney-targeted Birt–Hogg–Dubé gene inactivation in a mouse model: Erk1/2 and Akt–mTOR activation, cell hyperproliferation, and polycystic kidneys. J. Natl. Cancer Inst. 100, 140–154 (2008).
pubmed: 18182616 pmcid: 2704336
Chen, J. et al. Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. PLoS ONE 3, e3581 (2008).
pubmed: 18974783 pmcid: 2570491
Palmieri, M. et al. Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum. Mol. Genet. 20, 3852–3866 (2011).
pubmed: 21752829
Wada, S. et al. The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue. Genes Dev. 30, 2551–2564 (2016).
pubmed: 27913603 pmcid: 5159669
Anandapadamanaban, M. et al. Architecture of human Rag GTPase heterodimers and their complex with mTORC1. Science 366, 203–210 (2019).
pubmed: 31601764 pmcid: 6795536
Rogala, K. B. et al. Structural basis for the docking of mTORC1 on the lysosomal surface. Science 366, 468–475 (2019).
pubmed: 31601708 pmcid: 7176403
Kauffman, E. C. et al. Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. Nat. Rev. Urol. 11, 465–475 (2014).
pubmed: 25048860 pmcid: 4551450
Calcagnì, A. et al. Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling. eLife 5, e17047 (2016).
pubmed: 27668431 pmcid: 5036965
Perera, R. M., Di Malta, C. & Ballabio, A. MiT/TFE family of transcription factors, lysosomes, and cancer. Annu Rev Cancer Biol 3, 203–222 (2019).
pubmed: 31650096
Baba, M. et al. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc. Natl Acad. Sci. USA 103, 15552–15557 (2006).
pubmed: 17028174
Petit, C. S., Roczniak-Ferguson, A. & Ferguson, S. M. Recruitment of folliculin to lysosomes supports the amino acid-dependent activation of Rag GTPases. J. Cell Biol. 202, 1107–1122 (2013).
pubmed: 24081491 pmcid: 3787382
Mansueto, G. et al. Transcription factor EB controls metabolic flexibility during exercise. Cell Metab. 25, 182–196 (2017).
pubmed: 28011087 pmcid: 5241227
Endoh, M. et al. A FLCN–TFE3 feedback loop prevents excessive glycogenesis and phagocyte activation by regulating lysosome activity. Cell Rep. 30, 1823–1834 (2020).
pubmed: 32049013
Possik, E. et al. FLCN and AMPK confer resistance to hyperosmotic stress via remodeling of glycogen stores. PLoS Genet. 11, e1005520 (2015).
pubmed: 26439621 pmcid: 4595296
Perera, R. M. et al. Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism. Nature 524, 361–365 (2015).
pubmed: 26168401 pmcid: 5086585
Kawakami, K. Tol2: a versatile gene transfer vector in vertebrates. Genome Biol. 8, S7 (2007).
pubmed: 18047699 pmcid: 2106836
de Araujo, M. E. G. et al. Crystal structure of the human lysosomal mTORC1 scaffold complex and its impact on signaling. Science 358, 377–381 (2017).
pubmed: 28935770
Napolitano, G. et al. Impairment of chaperone-mediated autophagy leads to selective lysosomal degradation defects in the lysosomal storage disease cystinosis. EMBO Mol. Med. 7, 158–174 (2015).
pubmed: 25586965 pmcid: 4328646
Shao, X., Johnson, J. E., Richardson, J. A., Hiesberger, T. & Igarashi, P. A minimal Ksp-cadherin promoter linked to a green fluorescent protein reporter gene exhibits tissue-specific expression in the developing kidney and genitourinary tract. J. Am. Soc. Nephrol. 13, 1824–1836 (2002).
pubmed: 12089378

Auteurs

Gennaro Napolitano (G)

Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.
Medical Genetics Unit, Department of Medical and Translational Science, Federico II University, Naples, Italy.

Chiara Di Malta (C)

Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.

Alessandra Esposito (A)

Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.

Mariana E G de Araujo (MEG)

Institute of Cell Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.

Salvatore Pece (S)

IEO, European Institute of Oncology IRCCS, Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

Giovanni Bertalot (G)

IEO, European Institute of Oncology IRCCS, Milan, Italy.

Maria Matarese (M)

Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.

Valerio Benedetti (V)

Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.

Angela Zampelli (A)

Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.

Taras Stasyk (T)

Institute of Cell Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.

Diletta Siciliano (D)

Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.

Alessandro Venuta (A)

Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.

Marcella Cesana (M)

Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.

Claudia Vilardo (C)

Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.

Edoardo Nusco (E)

Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.

Jlenia Monfregola (J)

Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.

Alessia Calcagnì (A)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, USA.

Pier Paolo Di Fiore (PP)

IEO, European Institute of Oncology IRCCS, Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

Lukas A Huber (LA)

Institute of Cell Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
Austrian Drug Screening Institute (ADSI), Innsbruck, Austria.

Andrea Ballabio (A)

Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy. ballabio@tigem.it.
Medical Genetics Unit, Department of Medical and Translational Science, Federico II University, Naples, Italy. ballabio@tigem.it.
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. ballabio@tigem.it.
Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, USA. ballabio@tigem.it.
SSM School for Advanced Studies, Federico II University, Naples, Italy. ballabio@tigem.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH